Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.87 |
| ▸ | FAAH | O00519 | 9/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20567305 | 0.93 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL25830289 | 0.89 | MGLL (0.69) | MGLLFAAH | |
| SCHEMBL25830349 | 0.86 | MGLL (0.65) | MGLLFAAHCYP3A4CYP2D6TSHR | |
| SCHEMBL24971552 | 0.86 | MGLL (0.84) | MGLLFAAH | |
| SCHEMBL25830362 | 0.84 | MGLL (0.61) | MGLLFAAH | |
| SCHEMBL25829953 | 0.83 | MGLL (0.65) | MGLLFAAH | |
| SCHEMBL25830157 | 0.83 | MGLL (0.60) | MGLLFAAH | |
| SCHEMBL20567708 | 0.81 | MGLL (0.80) | MGLLFAAH | |
| SCHEMBL25830401 | 0.81 | MGLL (0.62) | MGLLFAAH | |
| SCHEMBL25829823 | 0.81 | MGLL (0.57) | MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | MGLL 1/4885FAAH 33/4885CYP3A4 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.